Nicotinamide Riboside (NR) Market Growth Through 2030 Creates New Strategic Opportunities
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expAnded supply chain intelligence, emerging startup coverage, And detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable And strategically valuable research.
Nicotinamide Riboside (NR) Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The nicotinamide riboside (NR) market size has seen a rapid expansion in recent years. It is anticipated to rise from $1.81 billion in 2025 to $2.03 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. The historical growth can be primarily attributed to the increased embrace of nutraceutical supplements, a rising consumer focus on anti-aging solutions, enhanced understAnding of metabolic And mitochondrial well-being, the proliferation of online supplement sales channels, And more extensive pharmaceutical research into NAD? boosting compounds.
The nicotinamide riboside (NR) market is anticipated to show substantial expansion in the upcoming years, with projections indicating a rise to $3.23 billion by 2030, reflecting a compound annual growth rate (CAGR) of 12.3%. This growth during the forecast period is driven by factors such as the increasing demAnd for products supporting longevity And cellular rejuvenation, a growing interest in personalized wellness And precise nutrition, the rising integration of NR into multi-ingredient formulations, wider distribution through pharmacies And specialty health stores, And expAnding investments from nutraceutical And pharmaceutical producers. Significant trends for this period include technological advancements in NR formulation stability And bioavailability, innovations in delivery systems like sustained-release capsules, developments in fortifying functional foods And beverages with NR, ongoing research And development in NAD+ pathway therapeutics, And progress in customizing supplements using DNA And biomarker data.
Download A Free Sample Report For Comprehensive Market Insights:
Nicotinamide Riboside (NR) Market Growth Drivers: What Factors Are Accelerating Expansion?
The increasing health awareness among individuals is anticipated to boost the expansion of the nicotinamide riboside (NR) market in the future. This consumer health consciousness signifies individuals’ understAnding And preventive approach to preserving well-being via their lifestyle habits And nutritional selections. The surge in mindful eating stems from a growing recognition of illnesses linked to diet, encouraging a greater number of individuals to opt for wholesome foods And cut back on sugar consumption. Consumer health awareness boosts the uptake of nicotinamide riboside (NR) by fueling demAnd for supplements that aid cellular energy, support healthy aging, And promote metabolic processes. This factor contributes to market expansion by fostering proactive health practices And an interest in nutritional components validated by science. For example, data from June 2024, released by the International Food Information Council, a US nonprofit, indicates a growing emphasis among most Americans on higher protein intake, with figures climbing from 59% in 2022 to 67% in 2023 And 71% in 2024. Consequently, the expAnding health consciousness among consumers is propelling the advancement of the nicotinamide riboside (NR) market.
Nicotinamide Riboside (NR) Market Segment Performance And Strategic Opportunities
The nicotinamide riboside (nr) market covered in this report is segmented –
1) By Product Type: Capsules, Tablets, Powders, Other Product Types
2) By Distribution Channel: Online Retail, Health And Wellness Stores, Pharmacies And Drugstores, Supermarkets And Hypermarkets, Specialty Stores
3) By Application: Dietary Supplements, Pharmaceuticals, Cosmetics And Personal Care Products, Food And Beverage, Animal Nutrition
4) By End-User: Fitness Enthusiasts, Aging Population, General Consumers, Healthcare Institutions, Research And Academic Institutions
Subsegments:
1) By Capsules: Vegetarian Capsules, Gelatin Capsules, Sustained Release Capsules, Fast Dissolution Capsules, Enteric Coated Capsules
2) By Tablets: Coated Tablets, Chewable Tablets, Effervescent Tablets, Sublingual Tablets, Extended Release Tablets
3) By Powders: Flavored Powders, Unflavored Powders, Water Soluble Powders, Effervescent Powders, Single Serve Sachet Powders
4) By Other Product Types: Softgels, Liquid Oral Drops, Gummies, Functional Beverages, Fortified Food Products
Nicotinamide Riboside (NR) Market Trends: What Is Shaping Future Industry Growth?
Leading companies within the nicotinamide riboside (NR) market are prioritizing the creation of advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to aid in anti-aging efforts And enhance skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements refer to products, either consumed orally or applied topically, that are specifically developed to boost nicotinamide adenine dinucleotide (NAD+) concentrations in skin cells, thereby bolstering cellular energy, repair mechanisms, And anti-aging processes to improve both skin health And its appearance. Illustratively, in April 2024, ChromaDex Corporation, a US-based NAD+ bioscience company, introduced Tru Niagen at The Vitamin Shoppe. This healthy-aging nicotinamide adenine dinucleotide (NAD+) supplement is engineered to safely And efficiently elevate NAD? levels in adults, thereby supporting cellular health, energy production, And overall well-being. The product’s nationwide availability ensures that consumers desiring scientific backing for age-related reductions in metabolic function can easily access it.
Nicotinamide Riboside (NR) Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the nicotinamide riboside (nr) market are Zhejiang NHU Company Ltd., Designs for Health Inc., Niagen Bioscience Inc., Cayman Chemical Company, Jinan Qinmu Fine Chemical Co. Ltd, Simson Pharma Limited, Runtai Chemical, Double Wood Supplements LLC, DoNotAge.org Ltd., Bontac Bio-engineering (Shenzhen) Co. Ltd., Hangzhou Longshine Bio-Tech Co. LTD, Renue By Science LLC, Kavya Pharma, China Qingdao Hong Jin Chemical Co. Ltd., Chemvon Biotechnology (Shanghai) Co. Ltd., Dravyom Chemical Company, Fengchen Group Co. Ltd, Hangzhou Weitai Biological Pharmaceutical Co. Ltd., Suzhou MylAnd Nutraceuticals Inc., Chromadex Inc.
Access The Complete Nicotinamide Riboside (NR) Market Report:
Nicotinamide Riboside (NR) Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the nicotinamide riboside market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide riboside (nr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
